Australia markets closed

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.77-0.46 (-4.10%)
At close: 4:00PM EDT
10.60 -0.17 (-1.58%)
After hours: 05:17PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.23
Open11.13
Bid10.35 x 800
Ask11.39 x 900
Day's range10.65 - 11.13
52-week range8.72 - 34.71
Volume89,183
Avg. volume199,035
Market cap492.54M
Beta (5Y monthly)2.22
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Cellectis SA (CLLS) Q2 2021 Earnings Call Transcript

    At this time, I'll now turn the conference over to Eric Dutang, Chief Financial Officer. Thank you, and welcome everyone to Cellectis' second quarter 2021 corporate update and financial results conference call. Joining me on the call today with prepared remarks is Dr. Andre Choulika, our Chief Executive Officer; Dr. Carrie Brownstein, our Chief Medical Officer; and Steve Doares, our Senior Vice President of U.S. Manufacturing will be joining for the Q&A.

  • Motley Fool

    2 Risky Life-Sciences Stocks to Avoid and 1 to Buy Now

    Enthusiasm for life-sciences stocks may be at an all-time high, but it's easy to lose your shirt when dealing with companies on the cutting edge like Calyxt (NASDAQ: CLXT) and Zymergen (NASDAQ: ZY). Both of these companies have huge potential for growth, but investors probably want to watch them from a safe distance for now. After discussing what to avoid, I'll also show you why Thermo Fisher Scientific (NYSE: TMO) is one of the best life-sciences stocks you can buy now.

  • Motley Fool

    Cellectis SA (CLLS) Q4 2020 Earnings Call Transcript

    CLLS earnings call for the period ending December 31, 2020.